Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
- 1 June 1993
- journal article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 55 (6), 1365-1374
- https://doi.org/10.1016/0003-4975(93)91072-u
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancerCancer, 1992
- Randomized trial of neoadjuvant therapy for lung cancer: Interim analysisThe Annals of Thoracic Surgery, 1992
- Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lungThe Annals of Thoracic Surgery, 1992
- Neoadjuvant treatment in locally advanced non‐small cell lung cancerSeminars in Surgical Oncology, 1990
- Neoadjuvant chemotherapy in marginally resectable stage III M0 non‐small cell lung cancer: Long‐term follow‐up in 41 patientsJournal of Surgical Oncology, 1989
- The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0)The Annals of Thoracic Surgery, 1988
- Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trialCancer, 1987
- Simultaneous Cisplatin Fluorouracil Infusion and Radiation Followed by Surgical Resection in Regionally Localized Stage III, Non–Small Cell Lung CancerThe Annals of Thoracic Surgery, 1987
- Results of Resection in Non-Oat Cell Carcinoma of the Lung with Mediastinal Lymph Node MetastasesAnnals of Surgery, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958